Perkins Capital Management Inc Eli Lilly & CO Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Perkins Capital Management Inc holds 12,376 shares of LLY stock, worth $9.75 Million. This represents 10.79% of its overall portfolio holdings.

Number of Shares

12,376

Previous 12,622 1.95%

Holding current value

$9.75 Million

Previous $11.4 Million 4.05%

% of portfolio

10.79%

Previous 11.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $189,946 - $236,164	-246 Reduced 1.95%	12,376 $11 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $10,873 - $13,635	-15 Reduced 0.12%	12,622 $11.4 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $76,986 - $102,996	-130 Reduced 1.02%	12,637 $9.83 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $139,175 - $164,069	-265 Reduced 2.03%	12,767 $7.44 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $3,912 - $5,393	-9 Reduced 0.07%	13,032 $7 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $35,074 - $46,898	-100 Reduced 0.76%	13,041 $6.12 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $23,297 - $27,361	-75 Reduced 0.57%	13,141 $4.51 Million
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $56,924 - $64,871	-192 Reduced 1.43%	13,216 $4.27 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $67,455 - $83,712	-300 Reduced 2.19%	13,408 $3.7 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $32,615 - $43,157	-250 Reduced 1.79%	13,708 $2.31 Million
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $14,622 - $16,913	-100 Reduced 0.71%	13,958 $2.07 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $5,000 - $6,188	-42 Reduced 0.3%	14,058 $1.95 Million
Q4 2019 Feb 03, 2020	SELL	$106.92 - $132.43 $471,517 - $584,016	-4,410 Reduced 23.82%	14,100 $1.85 Million
Q3 2019 Oct 23, 2019	SELL	$106.79 - $116.16 $184,212 - $200,376	-1,725 Reduced 8.52%	18,510 $2.07 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $52,625 - $61,427	-475 Reduced 2.29%	20,235 $2.24 Million
Q1 2019 Apr 22, 2019	SELL	$111.31 - $131.02 $322,799 - $379,958	-2,900 Reduced 12.28%	20,710 $2.69 Million
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $90,840 - $104,256	-1,200 Reduced 4.84%	23,610 $2.02 Million
Q1 2018 Apr 23, 2018	BUY	$74.21 - $87.6 $290,161 - $342,516	3,910 Added 18.71%	24,810 $1.92 Million
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $221,238 - $237,303	2,700 Added 14.84%	20,900 $1.77 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $1.4 Million - $1.56 Million	18,200	18,200 $1.56 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Eli Lilly & CO Transaction History